Drugs / MPC-2130
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00387153 | Aug 2005 → Oct 2006 | cancer | Myriad Therapeutics, Inc. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MPC-2130 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00387153 ↗ |
| Route | Intravenous | “administered by intravenous infusion” NCT00387153 ↗ |